Cited by 35Tryptophan and brain disordersImmunotoxicology and immune responsesDrug-Induced Hepatotoxicity and Protection

N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons

Open access
Alboni, Silvia, Gibellini, Lara, Montanari, Claudia, Benatti, Cristina, Benatti, Stefania, Tascedda, Fabio, Brunello, Nicoletta, Cossarizza, Andrea +1 more·2013·International Journal of Neuropsychopharmacology

Abstract

Currently IFN-α is widely used for effective treatment of viral infections and several malignancies. However, IFN-α can cause neuropsychiatric disturbances and mental impairments, including fatigue, insomnia, depression, irritability and cognitive deficits. Molecular and cellular mechanisms leading to such side-effects are still poorly understood. Neurons seem to be an important target in mediating cellular effects induced by exposure to this cytokine, but so far little is known about IFN-α-induced effects on these cells. We have investigated the ability of IFN-α (2-100 ng/ml) to induce damage and toxicity to the human neuroblastoma SH-SY5Y cell line, commonly used for studying such phenomena, and the mechanisms underlying these effects. After 24 h treatment, IFN-α increased mitochondrial activity, whereas cell density was reduced in a dose- and time-dependent manner. This effect did not depend on reduced cell proliferation, but rather the activation of apoptosis, as revealed by an increased Bax:Bcl-2 mRNA ratio after 72-h IFN-α exposure. At this time-point, IFN-α also reduced the expression of the brain-derived neurotrophic factor gene, and induced an increase in reactive oxygen species (ROS). A co-treatment with N-acetyl-cysteine (NAC; 5 mm), a potent antioxidant and mitochondrial modulator, was able to counteract all of these IFN-α-induced effects. These findings demonstrated that IFN-α induces neurotoxicity and apoptosis that is, in part, very likely due to mitochondrial damages and production of ROS. We suggest that NAC, already tested for the treatment of psychiatric disorders, may be useful to prevent IFN-α-induced central side-effects in a safe and effective way.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145713000266

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Ignatowski TA and Spengler RN (2008) Cytokines and the brain (neuroimmune biology). Amsterdam: Elsevier.
  2. Leutscher PD, Lagging M, Buhl MR, Pedersen C, Norkrans G, Langeland N, Mørch K, Färkkilä M, Hjerrild S, Hellstrand NAC counteracts neurotoxicity caused by IFN-α 1863 Downloaded from https://academic.oup.com/ijnp/article/16/8/1849/816841 by guest on 18 August 2023

Cited by

Sorted by citations

Authors
Alboni, S., Gibellini, L., Montanari, C., Benatti, C., Benatti, S., Tascedda, F., Brunello, N., Cossarizza, A., & Pariante, C. M.
Affiliations
  • University of Modena and Reggio Emilia (IT)
  • King's College London (GB)
Venue
International Journal of Neuropsychopharmacology
Published
2013-09-01
Volume
16
Issue
8
Pages
1849-1865
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2141096613
Cited by
35
References
70
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 4 · 2013: 1
FWCI
1.47
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • European College of Neuropsychopharmacology
  • Società Italiana di Farmacologia
  • Medical Research Council (MR/J002739/1)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
interferon-alpha, N-acetylcysteine, neurotoxicity, apoptosis, reactive oxygen species, mitochondrial damage, oxidative stress, Bax/Bcl-2 ratio, brain-derived neurotrophic factor, SH-SY5Y cells, antioxidant defense
MeSH terms
Acetylcysteine, Analysis of Variance, Bromodeoxyuridine, Cell Differentiation, Dose-Response Relationship, Drug, Flow Cytometry, Gene Expression Regulation, Humans, Neuroblastoma, RNA, Messenger, Time Factors, Tretinoin, Tumor Necrosis Factor-alpha, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Brain-Derived Neurotrophic Factor, Proto-Oncogene Proteins c-bcl-2, In Situ Nick-End Labeling, Cell Line, Tumor, Cell Proliferation, bcl-2-Associated X Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review